Integral Diagnostics Limited (ASX:IDX)
Australia
· Delayed Price · Currency is AUD 2.890
-0.060 (-2.03%)
Feb 21, 2025, 4:10 PM AEST
Integral Diagnostics Income Statement
Financials in millions AUD. Fiscal year is July - June.
Millions AUD. Fiscal year is Jul - Jun.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|
Period Ending | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 | Jun '20 Jun 30, 2020 | 2019 - 2015 |
| Revenue | 469.7 | 440.76 | 360.93 | 350.7 | 275.57 | Upgrade
|
| Revenue Growth (YoY) | 6.56% | 22.12% | 2.92% | 27.26% | 18.58% | Upgrade
|
| Cost of Revenue | 317.8 | 298.34 | 238.83 | 221.7 | 176.34 | Upgrade
|
| Gross Profit | 151.9 | 142.43 | 122.1 | 128.99 | 99.23 | Upgrade
|
| Selling, General & Admin | 25.75 | 23.39 | 21.17 | 19.64 | 14.64 | Upgrade
|
| Research & Development | 15.42 | 12.94 | - | - | - | Upgrade
|
| Other Operating Expenses | 20.7 | 22.3 | 26.24 | 22.98 | 19.14 | Upgrade
|
| Operating Expenses | 109.73 | 103.96 | 83.47 | 79.62 | 60.8 | Upgrade
|
| Operating Income | 42.17 | 38.47 | 38.62 | 49.37 | 38.43 | Upgrade
|
| Interest Expense | -22.31 | -18.3 | -10.48 | -8.82 | -8.56 | Upgrade
|
| Interest & Investment Income | 0.86 | 0.42 | 0.04 | 0.09 | 0.27 | Upgrade
|
| Earnings From Equity Investments | -0.06 | -0.33 | -0.16 | 0.02 | - | Upgrade
|
| Currency Exchange Gain (Loss) | - | - | - | 0.18 | 0.02 | Upgrade
|
| Other Non Operating Income (Expenses) | -0.23 | -0.05 | - | -0.09 | - | Upgrade
|
| EBT Excluding Unusual Items | 20.42 | 20.22 | 28.02 | 40.75 | 30.16 | Upgrade
|
| Merger & Restructuring Charges | -2.92 | 10.41 | -5.46 | -2.22 | -5.14 | Upgrade
|
| Impairment of Goodwill | -71.6 | - | - | - | - | Upgrade
|
| Asset Writedown | -3.04 | - | - | - | - | Upgrade
|
| Other Unusual Items | - | - | - | 6.7 | 10.24 | Upgrade
|
| Pretax Income | -57.14 | 30.63 | 22.56 | 45.22 | 35.26 | Upgrade
|
| Income Tax Expense | 3.56 | 5.59 | 7.96 | 13.95 | 12.23 | Upgrade
|
| Earnings From Continuing Operations | -60.7 | 25.04 | 14.6 | 31.27 | 23.03 | Upgrade
|
| Net Income | -60.7 | 25.04 | 14.6 | 31.27 | 23.03 | Upgrade
|
| Net Income to Common | -60.7 | 25.04 | 14.6 | 31.27 | 23.03 | Upgrade
|
| Net Income Growth | - | 71.47% | -53.30% | 35.75% | 9.77% | Upgrade
|
| Shares Outstanding (Basic) | 233 | 233 | 209 | 198 | 185 | Upgrade
|
| Shares Outstanding (Diluted) | 236 | 236 | 212 | 200 | 187 | Upgrade
|
| Shares Change (YoY) | 0.23% | 11.29% | 5.70% | 7.16% | 18.43% | Upgrade
|
| EPS (Basic) | -0.26 | 0.11 | 0.07 | 0.16 | 0.12 | Upgrade
|
| EPS (Diluted) | -0.26 | 0.11 | 0.07 | 0.16 | 0.12 | Upgrade
|
| EPS Growth | - | 53.62% | -55.77% | 26.73% | -7.37% | Upgrade
|
| Free Cash Flow | 42.28 | 23.28 | 9.33 | 49.31 | 28.37 | Upgrade
|
| Free Cash Flow Per Share | 0.18 | 0.10 | 0.04 | 0.25 | 0.15 | Upgrade
|
| Dividend Per Share | 0.058 | 0.060 | 0.070 | 0.125 | 0.095 | Upgrade
|
| Dividend Growth | -3.33% | -14.29% | -44.00% | 31.58% | -5.00% | Upgrade
|
| Gross Margin | 32.34% | 32.31% | 33.83% | 36.78% | 36.01% | Upgrade
|
| Operating Margin | 8.98% | 8.73% | 10.70% | 14.08% | 13.95% | Upgrade
|
| Profit Margin | -12.92% | 5.68% | 4.05% | 8.92% | 8.36% | Upgrade
|
| Free Cash Flow Margin | 9.00% | 5.28% | 2.58% | 14.06% | 10.30% | Upgrade
|
| EBITDA | 71.55 | 66.08 | 62.22 | 72.59 | 54.64 | Upgrade
|
| EBITDA Margin | 15.23% | 14.99% | 17.24% | 20.70% | 19.83% | Upgrade
|
| D&A For EBITDA | 29.38 | 27.61 | 23.6 | 23.22 | 16.21 | Upgrade
|
| EBIT | 42.17 | 38.47 | 38.62 | 49.37 | 38.43 | Upgrade
|
| EBIT Margin | 8.98% | 8.73% | 10.70% | 14.08% | 13.95% | Upgrade
|
| Effective Tax Rate | - | 18.26% | 35.27% | 30.86% | 34.68% | Upgrade
|
| Revenue as Reported | 470.56 | 441.21 | 360.97 | 350.96 | 275.86 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.